Correlation Between Abcellera Biologics and MGIC Investment

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and MGIC Investment at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and MGIC Investment into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and MGIC Investment Corp, you can compare the effects of market volatilities on Abcellera Biologics and MGIC Investment and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of MGIC Investment. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and MGIC Investment.

Diversification Opportunities for Abcellera Biologics and MGIC Investment

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Abcellera and MGIC is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and MGIC Investment Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MGIC Investment Corp and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with MGIC Investment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MGIC Investment Corp has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and MGIC Investment go up and down completely randomly.

Pair Corralation between Abcellera Biologics and MGIC Investment

Given the investment horizon of 90 days Abcellera Biologics is expected to generate 2.16 times more return on investment than MGIC Investment. However, Abcellera Biologics is 2.16 times more volatile than MGIC Investment Corp. It trades about 0.08 of its potential returns per unit of risk. MGIC Investment Corp is currently generating about -0.15 per unit of risk. If you would invest  272.00  in Abcellera Biologics on September 22, 2024 and sell it today you would earn a total of  13.00  from holding Abcellera Biologics or generate 4.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Abcellera Biologics  vs.  MGIC Investment Corp

 Performance 
       Timeline  
Abcellera Biologics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.
MGIC Investment Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MGIC Investment Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Abcellera Biologics and MGIC Investment Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abcellera Biologics and MGIC Investment

The main advantage of trading using opposite Abcellera Biologics and MGIC Investment positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, MGIC Investment can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MGIC Investment will offset losses from the drop in MGIC Investment's long position.
The idea behind Abcellera Biologics and MGIC Investment Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stocks Directory
Find actively traded stocks across global markets